Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Cancer Monoclonal Antibodies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Antibody Type
6.1 Murine Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Chimeric Antibodies
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Humanized Antibodies
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast

7 Market Breakup by Medication Type
7.1 Bevacizumab (Avastin)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Rituximab (Rituxan)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Trastuzumab (Herceptin)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cetuximab (Erbitux)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Panitumumab (Vectibix)
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast

8 Market Breakup by Application
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Blood Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Liver Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Brain Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Colorectal Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast

9 Market Breakup by End-User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Research Laboratories
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Others
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Amgen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Roche Holding AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 AbbVie Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Merck & Co., Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Genmab A/S
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 GlaxoSmithKline Plc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Bristol-Myers Squibb Company
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Novartis AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Spectrum Pharmaceuticals Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Seattle Genetics Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Pfizer Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Cancer Monoclonal Antibodies Market: Major Drivers and Challenges
Figure 2: Global: Cancer Monoclonal Antibodies Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cancer Monoclonal Antibodies Market: Breakup by Antibody Type (in %), 2021
Figure 4: Global: Cancer Monoclonal Antibodies Market: Breakup by Medication Type (in %), 2021
Figure 5: Global: Cancer Monoclonal Antibodies Market: Breakup by Application (in %), 2021
Figure 6: Global: Cancer Monoclonal Antibodies Market: Breakup by End-User (in %), 2021
Figure 7: Global: Cancer Monoclonal Antibodies Market: Breakup by Region (in %), 2021
Figure 8: Global: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Cancer Monoclonal Antibodies (Murine Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Cancer Monoclonal Antibodies (Murine Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Cancer Monoclonal Antibodies (Chimeric Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Cancer Monoclonal Antibodies (Chimeric Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Cancer Monoclonal Antibodies (Humanized Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Cancer Monoclonal Antibodies (Humanized Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Cancer Monoclonal Antibodies (Other Types of Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Cancer Monoclonal Antibodies (Other Types of Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Cancer Monoclonal Antibodies (Bevacizumab) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Cancer Monoclonal Antibodies (Bevacizumab) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Cancer Monoclonal Antibodies (Rituximab) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Cancer Monoclonal Antibodies (Rituximab) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Cancer Monoclonal Antibodies (Trastuzumab) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Cancer Monoclonal Antibodies (Trastuzumab) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Cancer Monoclonal Antibodies (Cetuximab) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Cancer Monoclonal Antibodies (Cetuximab) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Cancer Monoclonal Antibodies (Panitumumab) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Cancer Monoclonal Antibodies (Panitumumab) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Cancer Monoclonal Antibodies (Other Medication Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Cancer Monoclonal Antibodies (Other Medication Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Cancer Monoclonal Antibodies (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Cancer Monoclonal Antibodies (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Cancer Monoclonal Antibodies (Blood Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Cancer Monoclonal Antibodies (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Cancer Monoclonal Antibodies (Liver Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Cancer Monoclonal Antibodies (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Cancer Monoclonal Antibodies (Brain Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Cancer Monoclonal Antibodies (Brain Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Cancer Monoclonal Antibodies (Colorectal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Cancer Monoclonal Antibodies (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Cancer Monoclonal Antibodies (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Cancer Monoclonal Antibodies (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Cancer Monoclonal Antibodies (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Cancer Monoclonal Antibodies (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Cancer Monoclonal Antibodies (Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Cancer Monoclonal Antibodies (Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Cancer Monoclonal Antibodies (Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Cancer Monoclonal Antibodies (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Cancer Monoclonal Antibodies (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Cancer Monoclonal Antibodies (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: North America: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: North America: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: United States: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: United States: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Canada: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Canada: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Asia Pacific: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Asia Pacific: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: China: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: China: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Japan: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Japan: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: India: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: India: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: South Korea: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: South Korea: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Australia: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Australia: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Europe: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Europe: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Germany: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Germany: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: France: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: France: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: United Kingdom: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: United Kingdom: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Italy: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Italy: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Spain: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Spain: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Russia: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Russia: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Latin America: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Latin America: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Brazil: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Brazil: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Mexico: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Mexico: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Others: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Others: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Middle East and Africa: Cancer Monoclonal Antibodies Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Middle East and Africa: Cancer Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Global: Cancer Monoclonal Antibodies Industry: SWOT Analysis
Figure 96: Global: Cancer Monoclonal Antibodies Industry: Value Chain Analysis
Figure 97: Global: Cancer Monoclonal Antibodies Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Cancer Monoclonal Antibodies Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cancer Monoclonal Antibodies Market Forecast: Breakup by Antibody Type (in Million US$), 2022-2027
Table 3: Global: Cancer Monoclonal Antibodies Market Forecast: Breakup by Medication Type (in Million US$), 2022-2027
Table 4: Global: Cancer Monoclonal Antibodies Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Cancer Monoclonal Antibodies Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 6: Global: Cancer Monoclonal Antibodies Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Cancer Monoclonal Antibodies Market: Competitive Structure
Table 8: Global: Cancer Monoclonal Antibodies Market: Key Players